Covered recipient · General Payments record
ALYSSA ANN TOBE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2021–2024
$446.96
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $205.44 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $83.97 | 4 |
| Acerta Pharma LLC | $43.98 | 3 |
| Novo Nordisk AS | $26.96 | 2 |
| Abbott Laboratories | $17.60 | 1 |
| Lilly USA, LLC | $17.51 | 1 |
| ABBVIE INC. | $15.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $17.60 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125350734 | CMS |
| ABBVIE INC. | $15.42 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229029 | CMS |
| Amgen Inc. | $21.79 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117399382 | CMS |
| Amgen Inc. | $18.26 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117399384 | CMS |
| Amgen Inc. | $15.48 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117399386 | CMS |
| Amgen Inc. | $28.44 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111725667 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.35 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105715406 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.08 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105616273 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.55 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104492776 | CMS |
| Lilly USA, LLC | $17.51 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136020440 | CMS |
| Novo Nordisk Inc | $13.84 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096648468 | CMS |
| Novo Nordisk Inc | $13.12 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097598999 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.